Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Medial nucleus accumbens dopamine receptors modulate motivation for wheel running in male mice
    Published on 2025-06-12
    3 weeks ago
  • VTA-ACC dopaminergic circuit mediates trait anxiety-related observational learning of social avoidance in male mice
    Published on 2025-06-12
    3 weeks ago
  • The neural and psychophysiological effects of cannabidiol in youth with alcohol use disorder: A randomized controlled clinical trial
    Published on 2025-06-11
    3 weeks ago
  • Prefrontal corticotropin-releasing factor promotes resilience to social stress
    Published on 2025-06-10
    4 weeks ago
  • Sitagliptin as a therapeutic approach for social anxiety disorder: the role of DPP4 and NPY in modulating social fear and comorbid depressive-like behavior in mice
    Published on 2025-06-09
    4 weeks ago
  • Merkel cell stimulation in fear and sensory signaling
    Published on 2025-06-07
    4 weeks ago
  • Prelimbic cortical excitatory overdrive and inhibitory underdrive accompany environmental suppression of food seeking
    Published on 2025-06-06
    4 weeks ago
« Previous 1 2 3 4 5 … 143 Next »
Journal of Psychopharmacology
  • Functional connectivity alterations of the pregenual anterior cingulate cortex by ketamine and the modulation by lamotrigine
    Published on 2025-06-19
    2 weeks ago
  • Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects
    Published on 2025-06-19
    2 weeks ago
  • Naturalistic use of psychedelics is associated with longitudinal improvements in anxiety and depression during global crisis times
    Published on 2025-06-18
    2 weeks ago
  • Uncertainty about lithium and suicide: A response to Nassir Ghaemi
    Published on 2025-06-17
    2 weeks ago
  • Dissecting the pro-neurogenic effects of monoaminergic medications used to treat depression: a systematic review and meta-analysis
    Published on 2025-06-11
    3 weeks ago
  • A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy
    Published on 2025-06-10
    3 weeks ago
  • Six weeks open-label oral ketamine for patients with treatment-resistant depression, post-traumatic stress disorder, or obsessive-compulsive disorder
    Published on 2025-06-05
    4 weeks ago
« Previous 1 2 3 4 5 … 123 Next »
European Neuropsychopharmacology
  • Targeting hallucinations in schizophrenia: Improving research translation into clinical practice
    Published on 2025-05-23
    1 month ago
  • Making symptom measurement feasible: The clinical case for PANSS-6
    Published on 2025-05-23
    1 month ago
  • Comparative mortality risk of antipsychotics in 41,695 patients with schizophrenia: an 11-year population-based cohort study in Hong Kong
    Published on 2025-05-23
    1 month ago
  • Pharmacological treatments for atypical depression: A systematic review and network meta-analysis of randomized controlled trials
    Published on 2025-05-23
    1 month ago
  • Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003–2018
    Published on 2025-05-23
    1 month ago
  • Functioning Assessment Short Test (FAST): validity and reliability in adolescent and young adults with Borderline Personality Disorder (BPD)
    Published on 2025-05-23
    1 month ago
  • Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis
    Published on 2025-05-23
    1 month ago
« Previous 1 2 3 4 5 … 144 Next »

   Pharma Pub